Nephros, Inc.
NEPH
$4.19
$0.010.24%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 21.16% | 10.34% | -0.53% | 0.03% | 12.79% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 21.16% | 10.34% | -0.53% | 0.03% | 12.79% |
| Cost of Revenue | 12.01% | 4.39% | -6.75% | -6.59% | -5.08% |
| Gross Profit | 27.17% | 14.26% | 3.78% | 4.76% | 28.68% |
| SG&A Expenses | -6.75% | -12.78% | -13.86% | -0.87% | 9.35% |
| Depreciation & Amortization | -17.92% | -26.94% | -36.92% | -30.59% | -18.40% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.37% | -5.18% | -10.58% | -4.43% | 1.44% |
| Operating Income | 197.66% | 151.92% | 100.38% | 41.36% | 49.58% |
| Income Before Tax | 204.40% | 156.75% | 105.65% | 43.35% | 52.22% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 202.55% | 155.70% | 104.70% | 43.35% | 52.22% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 202.55% | 155.70% | 104.70% | 49.48% | 73.53% |
| EBIT | 197.66% | 151.92% | 100.38% | 41.36% | 49.58% |
| EBITDA | 223.89% | 170.77% | 110.37% | 43.13% | 51.37% |
| EPS Basic | 201.70% | 154.82% | 104.55% | 50.17% | 73.97% |
| Normalized Basic EPS | 203.37% | 155.74% | 105.38% | 46.74% | 56.75% |
| EPS Diluted | 191.01% | 148.82% | 100.32% | 54.72% | 73.70% |
| Normalized Diluted EPS | 202.98% | 155.74% | 105.38% | 46.74% | 56.75% |
| Average Basic Shares Outstanding | 0.79% | 1.07% | 1.33% | 1.52% | 1.71% |
| Average Diluted Shares Outstanding | 1.44% | 1.23% | 1.46% | 1.62% | 1.72% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |